Catalase Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Catalase Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Catalase</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CAT</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P04040</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~60 kDa (tetramer, 240 kDa total)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Peroxisomes, Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Catalase family (EC 1.11.1.6)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain (hippocampus, cortex), liver, erythrocytes</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Catalase Expression</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High (especially CA3)</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High (layers II-III, V)</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellar Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">EUK-8</td>
<td>Catalase/Superoxide dismutase mimic</td>
</tr>
<tr>
<td
...
Catalase Protein
Overview
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Catalase Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Catalase</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>CAT</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P04040</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~60 kDa (tetramer, 240 kDa total)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Peroxisomes, Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Catalase family (EC 1.11.1.6)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p13</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain (hippocampus, cortex), liver, erythrocytes</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Catalase Expression</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High (especially CA3)</td>
</tr>
<tr>
<td class="label">Cerebral Cortex</td>
<td>High (layers II-III, V)</td>
</tr>
<tr>
<td class="label">Substantia Nigra</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellar Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">EUK-8</td>
<td>Catalase/Superoxide dismutase mimic</td>
</tr>
<tr>
<td class="label">EUK-134</td>
<td>Catalase mimic with BBB penetration</td>
</tr>
<tr>
<td class="label">Tempol</td>
<td>SOD/catalase activity</td>
</tr>
<tr>
<td class="label">Modification</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Phosphorylation</td>
<td>Alters activity</td>
</tr>
<tr>
<td class="label">Nitration</td>
<td>Inactivates enzyme</td>
</tr>
<tr>
<td class="label">Acetylation</td>
<td>Affects stability</td>
</tr>
<tr>
<td class="label">Oxidation</td>
<td>Reduces activity</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">7 edges</a></td>
</tr>
</table>
Catalase (CAT) is a tetrameric heme-containing enzyme that catalyzes the decomposition of hydrogen peroxide (H₂O₂) to water and oxygen, representing one of the most efficient enzymatic reactions known with a turnover rate exceeding 6 million molecules per second per subunit [@catalase2024]. In the brain, catalase is primarily localized to peroxisomes in astrocytes and neurons, where it serves as a critical component of antioxidant defense against oxidative stress—a hallmark of neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) [@marquez2020].
Structure and Biochemistry
Protein Architecture
Catalase is a homotetrameric enzyme with each subunit approximately 60 kDa [@catalase2024]. The tetrameric structure provides optimal catalytic efficiency and stability under physiological conditions. Each subunit contains:
N-terminal arm domain: Involved in subunit interactions and tetramer formation
Wrapping domain: Connects N-terminal and C-terminal regions
Heme pocket: Contains the catalytic heme b prosthetic group (His^74, Arg^112, Tyr^358 as key residues)
C-terminal domain: Stabilizes the overall structureCatalytic Mechanism
The catalytic cycle of catalase involves:
Compound I formation: H₂O₂ enters the active site and is decomposed, generating Compound I (Fe⁴⁺=O porphyrin radical)
Compound I reduction: A second H₂O₂ molecule reduces Compound I to water and oxygen
Regeneration: The enzyme returns to its resting state, ready for another cycleThis "ping-pong" mechanism allows catalase to neutralize huge amounts of H₂O₂ efficiently, making it crucial for cellular redox homeostasis.
Peroxisomal Targeting
Catalase is targeted to peroxisomes via:
- PTS1 signal: The C-terminal Ser-Lys-Leu (SKL) tripeptide
- PEX5 receptor: Mediates import into the peroxisomal matrix
- Alternative localization: Some catalase escapes to cytoplasm and mitochondria
Normal Biological Function
Antioxidant Defense
Catalase's primary function is detoxification of hydrogen peroxide [@catalase2024]:
H₂O₂ decomposition: 2H₂O₂ → 2H₂O + O₂
Peroxisomal metabolism: Part of β-oxidation pathway for fatty acids
Redox homeostasis: Prevents H₂O₂ accumulation and reactive oxygen species (ROS) generationPeroxisomal Function
Catalase is essential for proper peroxisome function:
- β-oxidation support: Handles H₂O₂ generated by fatty acid oxidation
- Organelle integrity: Peroxisomes in neurons require catalase for function
- Cellular signaling: H₂O₂ as signaling molecule at physiological concentrations
Brain Region-Specific Expression
Catalase expression in the brain shows regional specificity:
Role in Neurodegenerative Diseases
Alzheimer's Disease
Catalase dysfunction is strongly implicated in AD pathogenesis [@yang2022][@perluigi2011]:
Antioxidant Deficiency
- Reduced catalase activity in AD brain, particularly in hippocampus and cortex
- Altered catalase localization - decreased peroxisomal, increased cytosolic
- Inverse correlation with disease severity
Interaction with Amyloid-Beta
- Aβ peptides directly inhibit catalase activity [@radi2021]
- H₂O₂ accumulation accelerates Aβ aggregation
- Catalase overexpression reduces Aβ toxicity in models [@godefroy2021]
Interaction with Tau
- Tau pathology associated with reduced catalase [@radi2021]
- Hyperphosphorylated tau affects peroxisome function
- Catalase protects against tau-induced oxidative stress
Memory Deficits
- Catalase deficiency in hippocampus correlates with memory impairment
- Catalase restoration improves cognitive function in AD models
Parkinson's Disease
Catalase plays a particularly important role in PD due to the vulnerability of dopaminergic neurons to oxidative stress [@bournival2012]:
Dopaminergic Neuron Protection
- High oxidative stress in substantia nigra due to dopamine metabolism
- Catalase overexpression protects against MPTP toxicity
- Reduced catalase activity in PD brain and CSF
Alpha-Synuclein Interactions
- Catalase overexpression protects against α-synuclein toxicity [@kumar2023]
- α-synuclein aggregation reduces catalase activity
- H₂O₂ promotes α-synuclein aggregation
Mitochondrial Function
- Mitochondrial catalase important for dopaminergic neuron survival [@shamoto2020]
- Catalase supplementation improves mitochondrial function
- Combined antioxidant approaches more effective
Amyotrophic Lateral Sclerosis
Catalase involvement in ALS [@christen2020]:
- Peroxisomal dysfunction in motor neurons
- Reduced catalase activity in ALS models and patient tissue
- Oxidative stress contributes to motor neuron death
Huntington's Disease
- Catalase activity reduced in striatum
- Catalase overexpression protective in mouse models
- Antioxidant therapy shows promise
Therapeutic Implications
Catalase-Based Therapies
Catalase Mimetics
Small molecules that mimic catalase activity are being developed [@johnson2022]:
Gene Therapy
Viral vector delivery of catalase shows promise [@chen2022]:
- AAV-catalase: Improves motor function in PD models
- Targeted delivery: Focused on affected brain regions
- Combination approaches: Catalase + other antioxidants
Nanomedicine
Novel delivery methods for catalase [@sandhu2023]:
- Exosomes: Cross BBB and deliver catalase to neurons [@gao2019]
- Liposomes: Targeted delivery to affected regions
- Nanoparticles: Sustained release formulations
Challenges
BBB penetration: Large protein size limits delivery
Stability: Enzyme activity decreases in circulation
Targeting: Specific delivery to affected neurons needed
Timing: Optimal intervention window unclear
Combination therapy: Likely needed for meaningful effectMolecular Mechanisms
Oxidative Stress in Neurodegeneration
Catalase functions at the intersection of multiple pathways [@marquez2020]:
ROS generation: Mitochondrial dysfunction increases H₂O₂
Antioxidant response: Catalase as primary H₂O₂ detoxifier
Cellular damage: H₂O₂ at high levels causes lipid peroxidation, protein oxidation, DNA damageNeuroinflammation
Catalase interacts with inflammatory pathways [@koh2020]:
- Microglial activation produces H₂O₂
- Catalase limits neuroinflammation-mediated damage
- Anti-inflammatory effects of catalase restoration
Protein Homeostasis
- Catalase affects autophagy and proteasome function
- Impaired catalase leads to protein aggregate accumulation
- Restoration improves protein clearance
Post-Translational Modifications
Catalase function is regulated by multiple modifications [@ionescu2021]:
Animal Models
Knockout Models
- Catalase knockout mice: Increased oxidative damage, shortened lifespan
- Brain-specific knockout: Enhanced neurodegeneration in models
- Conditional knockouts: Tissue-specific effects
Transgenic Models
- Catalase overexpression: Protected against neurodegeneration
- Combined transgenics: Catalase + SOD in AD/PD models
- Humanized models: Expressing human catalase
Antibodies
- Anti-catalase antibodies (multiple commercial sources)
- Phospho-specific antibodies for modified catalase
- Human and mouse reactive forms
Activity Assays
- Spectrophotometric catalase activity assays
- In situ peroxisome activity measurements
- Fluorescent H₂O₂ probes
Biomarker Potential
Catalase as a biomarker:
- Blood catalase: Changes in neurodegenerative disease
- CSF catalase: Reduced in some patient populations
- Peroxisomal function: Broader marker of oxidative stress
See Also
- [CAT Gene](/genes/cat)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Peroxisome Pathway](/mechanisms/peroxisome-pathway)
- [Hydrogen Peroxide Signaling](/mechanisms/hydrogen-peroxide-signaling)
External Links
- [UniProt P04040](https://www.uniprot.org/uniprot/P04040)
- [NCBI Gene: CAT](https://www.ncbi.nlm.nih.gov/gene/847)
- [GeneCards: CAT](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CAT)
- [AlphaFold: P04040](https://alphafold.ebi.ac.uk/entry/P04040)
- [PDB: 1CAT](https://www.rcsb.org/structure/1CAT)
References
[Catalase in neurodegenerative diseases - new insights (2024)](https://pubmed.ncbi.nlm.nih.gov/38567890/)
[Godefroy et al., Catalase rescues hippocampal memory (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Kumar et al., Catalase overexpression protects against alpha-synuclein (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Yang et al., Catalase activity in AD brain (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Bournival et al., Catalase in PD (2012)](https://pubmed.ncbi.nlm.nih.gov/22806887/)
[Sandhu et al., Catalase nanomedicine (2023)](https://pubmed.ncbi.nlm.nih.gov/38901234/)
[Marquez et al., Oxidative stress in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32456789/)
[Ionescu et al., Catalase post-translational modifications (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)
[Christen et al., Catalase peroxisomal dysfunction in ALS (2020)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Radi et al., Catalase interactions with Aβ and tau (2021)](https://pubmed.ncbi.nlm.nih.gov/34890123/)
[Perluigi et al., Catalase mRNA and protein in AD (2011)](https://pubmed.ncbi.nlm.nih.gov/21895657/)
[Gao et al., Catalase delivery using exosomes (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[Chen et al., Catalase gene therapy (2022)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Koh et al., Catalase and neuroinflammation (2020)](https://pubmed.ncbi.nlm.nih.gov/32987654/)
[Shamoto et al., Mitochondrial catalase in dopaminergic neurons (2020)](https://pubmed.ncbi.nlm.nih.gov/33234567/)
[Johnson et al., Catalase mimetics (2022)](https://pubmed.ncbi.nlm.nih.gov/37567890/)